🔗 Share this article

Chancellor Reeves has stated she is planning "targeted measures to deal with household expense pressures" in the upcoming financial statement.

During an interview with the BBC, she stated that lowering inflation is a shared responsibility of both the government and the central bank.

The UK's inflation rate is forecast to be the most elevated among the G7 developed nations this year and the following year.

Potential Energy Bill Measures

Reports indicate the government could take action to lower energy bills, for example by reducing the current 5% level of value-added tax charged on energy.

Another approach is to lower some of the regulatory levies currently included in bills.

Fiscal Limitations and Expert Expectations

The administration will receive the latest assessment from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these actions.

The consensus from most experts is that the Chancellor will have to declare higher taxes or expenditure reductions in order to meet her self-imposed borrowing rules.

Previously on the same day, calculations suggested there was a twenty-two billion pound deficit for the Treasury chief to address, which is at the more modest range of projections.

"It is a collective job between the Bank of England and the administration to further reduce some of the drivers of inflation," the Chancellor told the BBC in Washington, at the conferences of the IMF and World Bank.

Revenue Pledges and Global Concerns

While much of the focus has been on likely tax increases, the chancellor said the latest data from the OBR had not altered her vow to manifesto promises not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising international and trade concerns for the Budget tax moves, likely to be focused on those "wealthiest."

International Trade Tensions

Commenting on apprehensions about the UK's trade ties with China she said: "The UK's security interests invariably take priority."

Last week's declaration by China to strengthen export controls on critical minerals and other materials that are essential for advanced tech manufacturing led US President the US President to threaten an further 100% tariff on goods from the Asian country, raising the prospect of an full-scale trade war between the two largest economies.

The US Treasury Secretary called China's decision "commercial pressure" and "a international production control attempt."

Inquired about considering the US offer to join its battle with China, the Chancellor said she was "extremely troubled" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "bad for the international commerce and creates additional obstacles."

"It is my opinion there are areas where we need to challenge China, but there are also significant prospects to export to China's economy, including banking sector and other areas of the economic system. We've got to achieve that equilibrium correct."

The Treasury chief also stated she was working with international partners "on our own essential resources plan, so that we are reduced dependence."

Health Service Drug Pricing and Investment

Reeves also admitted that the cost the NHS spends on pharmaceuticals could go up as a result of current talks with the US government and its drugs companies, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping investments in the United Kingdom, with some blaming the modest returns they are obtaining.

Recently, the Science Minister said the cost the NHS spends on drugs would need to rise to stop companies and pharmaceutical investment leaving the United Kingdom.

Reeves told media: "It has been observed due to the cost structure, that drug testing, innovative medicines have not been available in the United Kingdom in the manner that they are in other European countries."

"The objective is to make sure that people getting treatment from the National Health Service are can receive the best critical medicines in the globe. And so we are reviewing all of that, and... looking to secure more capital into the UK."